Howard Burris, MD
SCRI Development Innovations, LLC · Sarch Cannon Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Howard Burris, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:11 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03217838 · Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.AstraZeneca · terminated · Acute Myeloid Leukaemia · principal investigator
- Ph1NCT02144051 · Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor TumorsAstraZeneca · completed · Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor · principal investigator
- Ph1NCT01767766 · Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic MalignanciesTG Therapeutics, Inc. · completed · Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma · study chair
- Ph1NCT01238952 · Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast CancerNippon Kayaku Co., Ltd. · completed · Advanced Solid Tumors, Metastatic Triple Negative Breast Cancer · principal investigator
- Ph1NCT00606879 · Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid TumorsSGX Pharmaceuticals, Inc. · terminated · Advanced Cancer · principal investigator
- Ph1NCT00495144 · A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid TumorsThreshold Pharmaceuticals · completed · Tumors, Hypoxia · principal investigator
- Ph1NCT00315861 · Topotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesSCRI Development Innovations, LLC · completed · Ovarian Cancer, Endometrial Cancer, Cervical Cancer · principal investigator
- Ph2NCT00193102 · Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast CancerSCRI Development Innovations, LLC · terminated · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.